U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07114718) titled 'Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study' on Aug. 03.
Brief Summary: Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Congenital Heart Disease
Congenital Heart Disease (CHD)
Intervention:
DEVICE: Ductus Arteriosus Stent
The eligible subjects will proceed to implantati...